Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T P Pretlow

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Cancer Research|July 1, 1989
5'-nucleotidase activity in prostatic carcinoma and benign prostatic hyperplasiaR R Rackley, T J Lewis, E M Preston, et al.
Gut|March 13, 2002
Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colonR G Hardy, C Tselepis, J Hoyland, et al.
Cancer Research|December 1, 1994
CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinomaM A Wainstein, F He, D Robinson, et al.
Cancer Research|November 1, 1982
Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasiaT G Pretlow, G B Whitehurst, T P Pretlow, et al.
International Journal of Cancer|November 21, 1991
Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasiaT G Pretlow, T P Pretlow, B Yang, et al.
In Vitro Cellular & Developmental Biology. Animal|August 26, 1999
A new human prostate carcinoma cell line, 22Rv1R M Sramkoski, T G Pretlow, J M Giaconia, et al.
Journal of the National Cancer Institute|April 16, 1998
Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancerD M Dawson, E G Lawrence, G T MacLennan, et al.
Cancer Research|July 1, 1996
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agarM Nagabhushan, C M Miller, T P Pretlow, et al.
Cancer Research|August 17, 2000
Prostate cancer and other xenografts from cells in peripheral blood of patientsT G Pretlow, S Schwartz, J M Giaconia, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Cancer Research|July 1, 1989
5'-nucleotidase activity in prostatic carcinoma and benign prostatic hyperplasiaR R Rackley, T J Lewis, E M Preston, et al.
Gut|March 13, 2002
Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colonR G Hardy, C Tselepis, J Hoyland, et al.
Cancer Research|December 1, 1994
CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinomaM A Wainstein, F He, D Robinson, et al.
Cancer Research|November 1, 1982
Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasiaT G Pretlow, G B Whitehurst, T P Pretlow, et al.
International Journal of Cancer|November 21, 1991
Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasiaT G Pretlow, T P Pretlow, B Yang, et al.
In Vitro Cellular & Developmental Biology. Animal|August 26, 1999
A new human prostate carcinoma cell line, 22Rv1R M Sramkoski, T G Pretlow, J M Giaconia, et al.
Journal of the National Cancer Institute|April 16, 1998
Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancerD M Dawson, E G Lawrence, G T MacLennan, et al.
Cancer Research|July 1, 1996
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agarM Nagabhushan, C M Miller, T P Pretlow, et al.
Cancer Research|August 17, 2000
Prostate cancer and other xenografts from cells in peripheral blood of patientsT G Pretlow, S Schwartz, J M Giaconia, et al.
Pageof 8